Matt Galsky and the Uromigos try to get to the bottom of whether these immune therapy data from ESMO 2020 have made any difference in treatment and future plans.
Matt Galsky and the Uromigos try to get to the bottom of whether these immune therapy data from ESMO 2020 have made any difference in treatment and future plans.